Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 201-939-0 | CAS number: 89-78-1
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Developmental toxicity / teratogenicity
Administrative data
- Endpoint:
- developmental toxicity
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: well documented and scientifically acceptable
Cross-reference
- Reason / purpose for cross-reference:
- read-across: supporting information
Reference
- Endpoint:
- developmental toxicity
- Type of information:
- read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- key study
- Justification for type of information:
- See 'Attached justification' document: Justification for a read-across approach from L-Menthol (CAS No 2216-51-5, EC No 218-690-9) [Source] to D/L-Menthol (CAS No 89-78-1, EC No 201-939-0) [Target].
- Reason / purpose for cross-reference:
- read-across source
- Dose descriptor:
- NOEL
- Effect level:
- 218 mg/kg bw/day (nominal)
- Based on:
- test mat.
- Remarks on result:
- other: no efects observed at the highest applied dose
- Abnormalities:
- no effects observed
- Dose descriptor:
- NOAEL
- Effect level:
- 218 mg/kg bw/day
- Based on:
- test mat.
- Sex:
- male/female
- Remarks on result:
- other: no effects observed at the highest applied dose
- Abnormalities:
- no effects observed
- Developmental effects observed:
- no
- Conclusions:
- The administration of up to 218 mg/kg (body weight) of the test material to pregnant rats for 10 consecutive days had no clearly descernible effect on nidation or on maternal or fetal survival. The number of abnormalities seen in either soft or skeletal tissues of the test groups did not differ from the number occurring spontaneously in the sham-treated controls.
- Executive summary:
The administration of up to 218 mg/kg (body weight) of the test material to pregnant rats for 10 consecutive days had no clearly descernible effect on nidation or on maternal or fetal survival. The number of abnormalities seen in either soft or skeletal tissues of the test groups did not differ from the number occurring spontaneously in the sham-treated controls.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 973
Materials and methods
- Principles of method if other than guideline:
- Virgin adult female albino rats (Wistar derived stock) were individually housed in mesh bottom cages in temperature and humidity-controlled quarters with free access to food and fresh tap water.
They were mated with young adult males, and observation of the vaginal sperm plug was considered Day 0 of gestation. Beginning on Day 6 and continuing daily through Day 15 of gestation, the females were dosed with the indicated dosage s by oral intubations. The controls were sham treated with the vehicle at a level equivalent to the group receiving the highest test dose.
Body weights were recorded on Days 0, 6, 11, 15, and 20 of gestation. All animals were observed daily for appearance and behavior with particular attention to food consumption and weight, in order to rule out any abnormalities which may have occurred as a result of anorexic effects in the pregnant female animal.
On Day 20 all dams were subjected to Caesarean section under surgical anesthesia and the numbers of implantation sites, resorption sites, and live and dead fetuses were recorded. The body weights of the live pups were also recorded. The urogenital tract of each dam was examined in detail for anatomical normality.
All fetuses were examined grossly for the presence of external congenital abnormalities. One-third of the fetuses of each litter underwent detailed visceral examinations employing l0 x magnification. The remaining two-thirds were cleared in potassium hydroxide (KOH), stained with alizarin red S dye and examined for skeletal defects. - GLP compliance:
- not specified
Test material
- Reference substance name:
- L-menthol
- EC Number:
- 218-690-9
- EC Name:
- L-menthol
- Cas Number:
- 2216-51-5
- Molecular formula:
- C10H20O
- IUPAC Name:
- (1R,2S,5R)-2-isopropyl-5-methyl-cyclohexanol
Constituent 1
- Specific details on test material used for the study:
- Menthol natural, brazilian (FDA 71-57).
Menthol natural, brazilian (FDA 71-57) is L-menthol (CAS 2216-51-5). L-menthol is a constituent of menthol racemic (CAS 89-78-1).
Test animals
- Species:
- rat
- Strain:
- Wistar
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- not specified
- Details on mating procedure:
- They were mated with young adult males, and observation of the vaginal sperm plug was considered Day 0 of gestation
- Duration of treatment / exposure:
- Beginning on Day 6 and continuing daily through Day 15 of gestation, the females were dosed with the indicated dosage s by oral intubations. The controls were sham treated with the vehicle at a level equivalent to the group receiving the highest test dose.
On Day 20 all dams were subjectcd to Cacsarean section under surgical anesthesia - Frequency of treatment:
- daily
- Duration of test:
- 20 days
- No. of animals per sex per dose:
- 22-23 animals/dose
- Control animals:
- other: sham treated with corn oil
- Details on study design:
- Sex: female
Results and discussion
Results: maternal animals
Effect levels (maternal animals)
- Dose descriptor:
- NOEL
- Effect level:
- 218 mg/kg bw/day (nominal)
- Based on:
- test mat.
- Remarks on result:
- other: no efects observed at the highest applied dose
Maternal abnormalities
- Abnormalities:
- no effects observed
Results (fetuses)
Effect levels (fetuses)
- Dose descriptor:
- NOAEL
- Effect level:
- 218 mg/kg bw/day
- Based on:
- test mat.
- Sex:
- male/female
- Remarks on result:
- other: no effects observed at the highest applied dose
Fetal abnormalities
- Abnormalities:
- no effects observed
Overall developmental toxicity
- Developmental effects observed:
- no
Any other information on results incl. tables
All dose groups: no clearly discernible effect on nidation or on maternal or fetal survival; the number of abnormalities seen in either soft or skeletal tissues not differing from the number occuring spontaneously in the controls.
Reproduction data:
Group: Dose (mg/kg): |
Sham | 2.18 | 10.15 | 47.05 | 218.0 |
Pregnancies Total. No. Died or aborted (before day 20) To term (on day 20) |
25 0 25 |
22 0 22 |
23 0 23 |
23 0 23 |
22 0 22 |
Live Litters Total No.* |
25 |
22 |
23 |
23 |
22 |
Implant sites total No. Average/dam* |
241 9.64 |
256 11.6 |
266 11.6 |
275 12.0 |
250 11.4 |
Resorptions Total No.* Dams with 1 or more sites resorbed Dams with all sites resorbed Per cent partial resorptions Per cent complete resorptions |
5 4 - 16 .0 - |
8 3 - 13.6 - |
- - - - - |
2 2 - 8.70 - |
4 4 - 18.2 - |
Live Fetuses Total No.. Average/dam* Sex ratio (M//F) |
236 9.44 0.79 |
248 11.3 1.07 |
266 11.6 0.72 |
273 11.9 0.82 |
246 11.2 0.85 |
Dead Fetuses Total* Dans with 1 or more dead Dams with all dead Per cent partial dead Per cent all dead |
- - - - - |
- - - - - |
- - - - - |
- - - - - |
- - - - - |
Average Fetus Weight, g |
3.82 |
3.82 |
3.82 |
3.85 |
3.88 |
* Includes only those dams examined at term.
Summary of skeletal findings*
Findings Dose (mg/kg) |
Sham |
2.18 |
10.15 |
47.05 |
218.0 |
Live Fetuses Examined (at term) |
167/25 |
175/22 |
183/23 |
190/23 |
173/22 |
Sternebrae Incomplete oss. Scrambled Bipartite Fused Extra Missing Other |
80/22 1/1 14/6 |
92/20 11/8 |
93/22 2/2 17/5 |
101/19 11/4 |
92/19 1/1 |
Ribs Incomplete oss. Fused/split Wavy Less than 12 More than 13 Other |
25/10 3/3 |
33/13 5/3 |
1/1 19/10 2/2 |
21/10 2/2 |
16/8 3/3 |
Vertebrae Incomplete oss. Scrambled Fused Extra ctrs. oss. Scoliosis Tail defects Other |
9/5 |
11/6 |
12/7
|
14/7 |
10/7 |
Skull Incomplete closure Missing Craniostosis Other |
41/16 |
46/15 |
63/16 |
67/20 |
49/17 |
Extremities Incomplete oss. Missing Extra |
1/1 |
|
|
|
|
Miscellaneous Hyoid; missing Hyoid; reduced |
18/13 13/10 |
18/8 25/1 |
27/12 16/10 |
22/13 20/10 |
15/9 19/7 |
* Numerator = Number of fetuses affected; Denominator = Number of litters
Summary of Soft Tissue Abnormalities
Group | Material | Dose level mg/kg |
Dam | Number of pubs |
Description |
254 | FDA 71 -57 | 10.15 | K 4044 K 4053 |
1 1 |
Petechiae Anophthalmia |
255 |
FDA 71 -57 |
40.05 |
K 4064 K 4066 K 4072 K 4075 K 4084 |
1 1 1 1 1 |
Hydrocephalus: lobster claw Anophthalmia Anophthalmia Gastroschisis Gastroschisis |
Applicant's summary and conclusion
- Executive summary:
The administration of up to 218 mg/kg (body weight) of the test material to pregnant rats for 10 consecutive days had no clearly descernible effect on nidation or on maternal or fetal survival. The number of abnormalities seen in either soft or skeletal tissues of the test groups did not differ from the number occurring spontaneously in the sham-treated controls.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.